Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 3/2013

01-03-2013 | Neuro

Cerebral vein changes in relapsing-remitting multiple sclerosis demonstrated by three-dimensional enhanced T 2 * -weighted angiography at 3.0 T

Authors: Chun Zeng, Xuan Chen, Yongmei Li, Yu Ouyang, Fajin Lv, Reshiana Rumzan, Zhongping Wang

Published in: European Radiology | Issue 3/2013

Login to get access

Abstract

Objective

To investigate characteristics of the internal cerebral veins (ICVs) and their main tributaries and the deep medullary veins (DMVs) in patients with relapsing-remitting MS (RRMS) with enhanced T 2 * -weighted angiography imaging (ESWAN).

Methods

Fifty-three RRMS patients and 53 normal controls underwent conventional MRI and ESWAN. ESWAN venograms were created by performing minimum intensity projections of the phase images, and the resulting venograms were used to observe characteristic vascular changes, including scores of the ICVs and their main tributaries and manifestations of the DMVs. Two experienced radiologists analysed all data.

Results

Patients showed decreased mean scores of the ICVs and their main tributaries compared with controls. The mean score in acute patients was higher than in stable patients. Furthermore, the DMVs diminished and shortened in 48 patients with longer disease duration, whereas the DMVs increased and elongated in 5 patients with shorter disease duration. The penetrating veins were well defined in 30 active lesions, whereas the veins were ill defined in 69 non-active lesions. Interestingly, well-defined penetrating veins were shown in 15 non-active lesions in the stable patients.

Conclusions

Enhanced T 2 * -weighted MR angiography can detect cerebral vein characteristics in relapsing-remitting MS patients, which may provide important information on the pathogenesis of MS.

Key Points

• Enhanced T 2 * -weighted magnetic resonance angiography (ESWAN) provides new insights into multiple sclerosis
• ESWAN venograms clearly demonstrate the internal cerebral and deep medullary veins
• The internal cerebral veins exhibit abnormalities in patients with relapsing-remitting MS
• Deep medullary veins exhibit different manifestations in patients with different disease duration
Literature
1.
Anderson VM, Wheeler-Kingshott CA, Abdel-Aziz K et al (2011) A comprehensive assessment of cerebellar damage in multiple sclerosis using diffusion tractography and volumetric analysis. Mult Scler 17:1079–1087PubMedCrossRef
2.
Lassmann H, Brück W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17:210–218PubMedCrossRef
3.
de Graaf WL, Zwanenburg JJ, Visser F et al (2012) Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR. Eur Radiol 22:221–231PubMedCrossRef
4.
Simon B, Schmidt S, Lukas C et al (2010) Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol 20:1675–1683PubMedCrossRef
5.
Hohlfeld R (1997) Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain 120:865–916PubMedCrossRef
6.
Ge Y, Law M, Herbert J, Grossman RI (2005) Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. AJNR Am J Neuroradiol 26:2316–2319PubMed
7.
Kermode AG, Thompson AJ, Tofts P et al (1990) Breakdown of the blood–brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 113:1477–1489PubMedCrossRef
8.
Tan IL, van Schijnde RA, Pouwels PJ et al (2000) MR venography of multiple sclerosis. AJNR Am J Neuroradiol 21:1039–1042PubMed
9.
Ge Y, Zohrabian VM, Grossman RI (2008) Seven-Tesla magnetic resonance imaging. New vision of microvascular abnormalities in multiple sclerosis. Arch Neurol 65:812–816PubMedCrossRef
10.
Haacke EM, Makki M, Yulin G et al (2009) Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 29:537–544PubMedCrossRef
11.
Putnam TJ (1935) Evidences of vascular occlusion in multiple sclerosis and encephalomyelitis. Arch Neuropsychol 32:1298–1321
12.
Adams CW, Poston RN, Buk SJ, Sidhu YS, Vipond H (1985) Inflammatory vasculitis in multiple sclerosis. J Neurol Sci 69:269–283PubMedCrossRef
13.
Adams CW (1988) Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 51:260–265PubMedCrossRef
14.
Law M, Saindane AM, Ge Y et al (2004) Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 231:645–652PubMedCrossRef
15.
Zamboni P, Galeotti R, Menegatti E et al (2009) Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 80:392–399PubMedCrossRef
16.
Hojnacki D, Zamboni P, Lopez-Soriano A et al (2010) Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls. Int Angiol 29:127–139PubMed
17.
Zamboni P, Galeotti R (2010) The chronic cerebrospinal venous insufficiency syndrome. Phlebology 25:269–279PubMedCrossRef
18.
Ge Y, Zohrabian VM, Osa EO et al (2009) Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J Magn Reson Imaging 29:1190–1194PubMedCrossRef
19.
Boeckh-Behrens T, Lutz J, Lummel N et al (2011) Susceptibility-weighted angiography (SWAN) of cerebral veins and arteries compared to TOF-MRA. Eur J Radiol 81:1238–1245
20.
Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302PubMedCrossRef
21.
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMedCrossRef
22.
Haacke EM, Xu Y, Cheng YC, Reichenbach JR (2004) Susceptibility weighted imaging (SWI). Magn Reson Med 52:612–618PubMedCrossRef
23.
Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG (2008) Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 70:2076–2078PubMedCrossRef
24.
Hammond KE, Metcalf M, Carvajal L et al (2008) Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 64:707–713PubMedCrossRef
25.
Varga AW, Johnson G, Babb JS et al (2009) White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci 282:28–33PubMedCrossRef
26.
Ge Y, Law M, Johnson G et al (2005) Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 26:1539–1547PubMed
27.
Adhya S, Johnson G, Herbert J et al (2006) Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 33:1029–1035PubMedCrossRef
28.
Inglese M, Adhya S, Johnson G et al (2008) Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab 28:164–171PubMedCrossRef
29.
D’haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J (2011) Vascular aspects of multiple sclerosis. Lancet Neurol 10:657–666PubMedCrossRef
30.
Minagar A, Jy W, Jimenez JJ et al (2011) Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 56:1319–1324CrossRef
31.
Aksungar FB, Topkaya AE, Yildiz Z, Sahin S, Turk U (2008) Coagulation status and biochemical and inflammatory markers in multiple sclerosis. J Clin Neurosci 15:393–397PubMedCrossRef
32.
Sheremata WA, Jy W, Horstman LL, Ahn YS, Alexander JS, Minagar A (2008) Evidence of platelet activation in multiple sclerosis. J Neuroinflammation 5:27PubMedCrossRef
33.
Wakefield AJ, More LJ, Difford J, McLaughlin JE (1994) Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 47:129–133PubMedCrossRef
34.
Zamboni P, Menegatti E, Weinstock-Guttman B et al (2009) The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. Funct Neurol 24:133–138PubMed
35.
Zamboni P, Menegatti E, Weinstock-Guttman B et al (2011) Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report. BMC Med 9:22PubMedCrossRef
36.
Kantarci F, Albayram S, Demirci NO et al (2011) Chronic cerebrospinal venous insufficiency: does ultrasound really distinguish multiple sclerosis subjects from healthy controls? Eur Radiol 22:970–979PubMedCrossRef
37.
Zivadinov R, Poloni GU, Marr K et al (2011) Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency. BMC Neurol 11:128PubMedCrossRef
38.
Hochmeister S, Grundtner R, Bauer J et al (2006) Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol 65:855–865PubMedCrossRef
39.
Thompson AJ, Polman CH, Miller DH et al (1997) Primary progressive multiple sclerosis. Brain 120:1085–1096PubMedCrossRef
Metadata
Title
Cerebral vein changes in relapsing-remitting multiple sclerosis demonstrated by three-dimensional enhanced T 2 * -weighted angiography at 3.0 T
Authors
Chun Zeng
Xuan Chen
Yongmei Li
Yu Ouyang
Fajin Lv
Reshiana Rumzan
Zhongping Wang
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
European Radiology / Issue 3/2013
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2637-5

Other articles of this Issue 3/2013

European Radiology 3/2013 Go to the issue

Breast

Novel technology of multimodal ultrasound tomography detects breast lesions

Neuro

Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression

Magnetic Resonance

Potentially relevant incidental findings on research whole-body MRI in the general adult population: frequencies and management

Computed Tomography

Diagnostic accuracy of 128-slice dual-source CT coronary angiography: a randomized comparison of different acquisition protocols

Chest

Morphological changes of the thoracic duct and accessory lymphatic channels in patients with chylothorax: detection with unenhanced magnetic resonance imaging

Breast

Performance comparison of single-view digital breast tomosynthesis plus single-view digital mammography with two-view digital mammography